Michael Rettig

14PUBLICATIONS
114CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Jan 09, 2026
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.

William C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova

|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.

Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude

|Aug 29, 2024
Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells.

Peter G Ruminski, Michael P Rettig, John F DiPersio

|Aug 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial.

Armin Ghobadi, Ibrahim Aldoss, Shannon Maude

Pageof 3

Frequent Collaborators

8 joint publications

John F DiPersio

3 joint publications

Julie O'Neal

3 joint publications

Julia Tianjiao Wang

3 joint publications

Mark A Fiala